Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Total Debt (2018 - 2020)

Historic Total Debt for Neurocrine Biosciences (NBIX) over the last 3 years, with Q3 2020 value amounting to $425.0 million.

  • Neurocrine Biosciences' Total Debt changed N/A to $425.0 million in Q3 2020 from the same period last year, while for Sep 2020 it was $425.0 million, marking a year-over-year change of. This contributed to the annual value of $408.8 million for FY2019, which is N/A changed from last year.
  • Neurocrine Biosciences' Total Debt amounted to $425.0 million in Q3 2020.
  • In the past 5 years, Neurocrine Biosciences' Total Debt registered a high of $425.0 million during Q3 2020, and its lowest value of $383.6 million during Q3 2018.
  • For the 3-year period, Neurocrine Biosciences' Total Debt averaged around $409.2 million, with its median value being $414.2 million (2019).